Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. MYO
MYO logo

MYO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Myomo Inc (MYO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.740
1 Day change
6.17%
52 Week Range
5.620
Analysis Updated At
2026/03/13
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Myomo Inc (MYO) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock's technical indicators are bearish, and while there is insider buying, the company's financial performance and profitability challenges raise concerns. The lack of significant positive catalysts and weak analyst sentiment further support a hold decision.

Technical Analysis

The MACD is negative and expanding downward, RSI is neutral at 36.023, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its key support level of 0.684, with resistance at 0.758. Overall, the technical trend is bearish.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
3

Positive Catalysts

  • Insiders are buying significantly, with a 493.46% increase in insider buying over the last month.

Neutral/Negative Catalysts

  • Revenue dropped by 5.93% YoY, and gross margin decreased by 3.96%. Analysts have lowered the price target from $4 to $3, citing reduced forecasts and a lower sales multiple.

Financial Performance

In Q4 2025, revenue decreased by 5.93% YoY to $11.35 million. Net income improved to -$3.81 million, up 1366.44% YoY, but the company remains unprofitable. EPS improved to -0.09, up 800% YoY, but still negative. Gross margin dropped to 68.56%, down 3.96% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Alliance Global maintains a Buy rating but has lowered the price target from $4 to $3 due to reduced forecasts and a lower sales multiple.

Wall Street analysts forecast MYO stock price to rise
5 Analyst Rating
Wall Street analysts forecast MYO stock price to rise
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 0.697
sliders
Low
4
Averages
5.75
High
10
Current: 0.697
sliders
Low
4
Averages
5.75
High
10
Alliance Global
Buy
downgrade
$4 -> $3
AI Analysis
2026-03-12
New
Reason
Alliance Global
Price Target
$4 -> $3
AI Analysis
2026-03-12
New
downgrade
Buy
Reason
Alliance Global lowered the firm's price target on Myomo to $3 from $4 and keeps a Buy rating on the shares following the Q4 report. The firm cites its lower forecasts and a reduced multiple of sales for the target cut.
H.C. Wainwright
H.C. Wainwright
Buy
downgrade
$5
2025-08-12
Reason
H.C. Wainwright
H.C. Wainwright
Price Target
$5
2025-08-12
downgrade
Buy
Reason
H.C. Wainwright lowered the firm's price target on Myomo to $5 from $9.50 and keeps a Buy rating on the shares. The firm says that while the company's Q2 ended well, there are warning signs ahead as Myomo reported that the number of patients added to its pipeline was significantly lower than expected.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MYO
Unlock Now

People Also Watch